AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

A physician’s perspective published by Being Patient argues that persistent cognitive concerns deserve more than reassurance based only on normal test scores. Subjective cognitive decline can have many causes and does not diagnose Alzheimer’s, but a detailed baseline, review of contributing factors and follow-up may help identify change over time.

People who report persistent changes in memory or thinking may merit closer assessment and follow-up even when cognitive test scores remain within the expected range, geriatrician Dr. Nathaniel Chin wrote in an article published by Being Patient on October 27, 2026. Chin said subjective cognitive decline can be an early point for evaluating risk, but stressed that it is a description of a person’s experience—not proof of Alzheimer’s disease.

Before you orderOffer from Amazon

Get health and wellness essentials delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Subjective cognitive decline (SCD) refers to a persistent sense that a person’s thinking has worsened from their previous level, despite testing that does not show objective impairment. Chin said a normal score can miss a meaningful change because many tests compare someone with people of similar age rather than with their own earlier abilities. A person who once performed well above average, for example, could lose ground and still score within the average range.

Chin distinguishes a brief screening from a comprehensive cognitive evaluation. Screening tests often take five to 15 minutes and sample a limited range of abilities. A fuller evaluation typically lasts an hour or more and examines memory, language, attention and executive functions such as planning and organizing. In his view, a careful assessment is needed before concluding that someone has SCD without measurable impairment.

He also recommends looking for explanations other than Alzheimer’s and, where possible, asking someone who knows the person well whether they have observed a change. Repeated testing can help establish whether abilities remain stable or decline consistently. Chin’s account is a clinical perspective, not a report of a new study or a claim that SCD itself predicts a particular diagnosis.

At a glance
reportWhen: Published October 27, 2026
The developmentBeing Patient published a physician’s account of how subjective cognitive decline may inform Alzheimer’s risk assessment and follow-up before standard testing shows impairment.

Why Normal Scores May Miss Change

The distinction matters because normal test results do not necessarily settle the question of whether someone’s cognition has changed. A single score reflects performance at one point in time and may not show a decline from that person’s earlier abilities. Establishing a baseline and checking again later can give clinicians more information than relying on one screening result alone.

At the same time, treating every memory concern as a sign of Alzheimer’s would be misleading. Chin notes that sleep difficulties, medication effects, depression or anxiety, illness, vascular disease, hearing loss, stress and normal aging can affect how sharp a person feels. The practical implication is a balanced approach: take persistent concerns seriously while investigating other possible contributors and avoiding premature conclusions.

Products Worth Considering

As an affiliate, we earn on qualifying purchases.

How Clinicians Assess SCD

Chin describes features sometimes grouped under the term “SCD plus,” developed by Dr. Frank Jessen of the University of Cologne and colleagues in the international Subjective Cognitive Decline Initiative. These features include memory-focused concerns; onset within the previous five years; onset at age 60 or older; worry about the change; persistence; seeking medical help; and confirmation from someone familiar with the person.

These features are not diagnostic. Chin says that when several are present together, they may justify closer attention. His comparison is between a person with long-standing, intermittent word-finding concerns linked to stress or poor sleep and someone in their 60s with a recent, persistent memory change that worries both them and a spouse. Both could score normally, but the pattern and history would lead him to assess them differently.

The source article also raises whether blood biomarkers, cerebrospinal fluid testing and amyloid PET can help determine whether Alzheimer’s-related biological changes are present before cognitive impairment. The supplied material ends as Chin introduces that question, so it does not provide his full discussion or specify who should receive those tests.

What SCD Can—and Cannot—Show

SCD does not identify its cause and cannot by itself establish Alzheimer’s disease. The features described as SCD plus may raise concern when they occur together, but Chin says none proves that Alzheimer’s is present. The material provided does not quantify how likely people with these features are to develop Alzheimer’s or specify a time frame for that risk.

It is also unclear from the supplied portion of the article how Chin recommends selecting patients for biomarker tests, how he weighs their benefits and limits, or what follow-up interval he favors. The piece introduces blood, spinal-fluid and imaging tests but does not include the rest of that discussion. No new research findings or clinical guideline changes are reported in the available material.

Baseline Testing and Continued Follow-Up

Chin’s proposed clinical response is to establish a thorough cognitive baseline, review health and lifestyle factors that could affect thinking, and seek observations from a trusted person when available. If concerns persist, repeated assessment may show whether performance is stable or changing. The article does not set a standard testing schedule or recommend that everyone with subjective concerns undergo biomarker testing.

For readers, the development is a physician’s argument for discussing ongoing changes with a qualified health professional rather than treating one normal screening as a final answer—or as evidence of Alzheimer’s. Further detail on biomarker use and the full scope of Chin’s recommendations is not present in the supplied source excerpt.

Key Questions

What is subjective cognitive decline?

SCD is a persistent feeling that memory or thinking has worsened from a person’s earlier level, even though comprehensive testing does not show objective impairment.

Does subjective cognitive decline mean someone has Alzheimer’s?

No. Chin describes SCD as an experience, not a diagnosis. Many other factors, including sleep, medications, mood, illness, hearing loss and stress, can affect perceived thinking ability.

Why might a normal test miss a change?

A score may be compared with people of similar age rather than with the individual’s previous performance. Someone can decline from a higher personal baseline and still score within the expected range.

What does “SCD plus” mean?

It refers to features that may make subjective decline more concerning, such as recent, persistent memory concerns, worry, seeking medical help, onset at an older age and confirmation by someone close to the person. These features do not prove Alzheimer’s.

What follow-up does Chin describe?

He favors a detailed baseline assessment, consideration of other causes and repeat testing over time when concerns persist. The supplied article excerpt does not give a specific follow-up schedule or biomarker-testing criteria.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

What to Look for in a Home Blood Pressure Monitor

Understanding what to look for in a home blood pressure monitor is crucial for accuracy and reliability—keep reading to find out more.

Louisiana Vibrio Vulnificus Outbreak

Louisiana health officials confirm an outbreak of Vibrio vulnificus affecting residents and visitors, raising health concerns along the Gulf Coast.

Why You Feel Stiffer After 60, And Why It’s Not Just Age

A Pilates instructor says stiffness often follows long periods of sitting and limited movement, though age and health conditions can also play a role.

Krankenkasse

Recent proposals for reforming Germany’s krankenkasse system aim to address rising costs and coverage issues, prompting political and public discussion.